The 7investing Podcast cover image

The Third Biologic Revolution with Vaxxinity CEO Mei Mei Hu

The 7investing Podcast

00:00

How Do You Target These Diseases?

The company is trying to develop a vaccine that can be the base line for long durability. It's also targeting altimers, parkinsons and hyclestral callerepuseas as potential new treatments. The team has raised more than $100 million in venture capital so far this year.

Play episode from 09:40
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app